Company Description

INNOVOTEX is a biopharmaceutical company developing next-generation cancer therapeutics through a proprietary macrocycle drug conjugate (MDC) platform. By combining targeted delivery with novel mechanisms of action, INNOVOTEX aims to overcome resistance and toxicity challenges associated with traditional chemotherapy and usher in a new era of tumor-specific, immune-enhancing cancer treatments.